lemzoparlimab,azacitidine
abbvie,i-mab
['lemzoparlimab', 'azacitidine,(-oral azaci),(-azacitidine oral)', '$imab', ' i-mab ']
$imab i-mab announces positive phase 2 data of lemzoparlimab in combination with azacitidine (aza) in patients with higher risk myelodysplastic syndrome at esmo 2022 